ArticleAnnals of hematology2025

Early allogeneic stem cell transplantation after melphalan-induced aplasia leads to long-term survival in patients with primary refractory AML.

Claudius Söhn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.